Defilade Capital Management »

BioMarin Pharmaceutical shares owned by Defilade Capital Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $39M 682k 57.22

More positions owned by Defilade Capital Management

Eli Lilly & Co. (LLY)
Pfizer (PFE)
Veeva Sys Cl A Com (VEEV)
BioMarin Pharmaceutical (BMRN)
Ptc Therapeutics I (PTCT)
Baxter International (BAX)
Insmed Com Par $.01 (INSM)
Zimmer Holdings (ZBH)
Insulet Corporation (PODD)
Thermo Fisher Scientific (TMO)
Abbott Laboratories (ABT)
Ascendis Pharma A/s Ord Shs (ASND)
Solventum Corp Com Shs (SOLV)
Medtronic SHS (MDT)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding BioMarin Pharmaceutical

BlackRock
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
Norges Bank Investment Management
Viking Global Investors
State Street Corporation
Vestal Point Capital
AQR Capital Management
FMR
Dimensional Fund Advisors
Geode Capital Management
Capital Research Global Investors
Deep Track Capital

View all funds holding BioMarin Pharmaceutical